Awiqli (Insulin Icodec-abae)

Awiqli (insulin icodec-abae) is a long-acting human insulin analog indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Recommended Dosage:
The recommended dosage of Awiqli (available as a single-patient-use FlexTouch pen) is administered subcutaneously once weekly on any day of the week on the same day each week. The Awiqli FlexTouch pen delivers doses in 10-unit increments and can deliver up to 700 units in a single injection. Individualize and titrate the dose based on the patient’s metabolic needs, blood glucose monitoring results, and glycemic control goal.

Recommended Dosage in Insulin Naïve Patients: The recommended weekly starting dose of Awiqli in insulin naïve patients is 70 units administered subcutaneously once weekly on the same day each week.

If a dose is missed, administer the missed dose as quickly as possible within 4 days. Resume the once-weekly dosing schedule, one week from the day the missed dose was administered. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. Increase blood glucose monitoring with missed doses.

• Medication errors or accidental overdose with Awiqli may cause severe hypoglycemia. Patients should carefully check insulin labels, prescribed dose, and injection timing before use. Always follow the physician’s instructions and monitor blood glucose regularly to reduce the risk of blood sugar episodes.
• Awiqli can cause hypoglycemia, especially when meals are skipped, physical activity increases, or insulin doses are incorrect. Symptoms may include sweating, confusion, shaking, dizziness, hunger, or a fast heartbeat. Patients should monitor glucose levels carefully and keep a sugar source available.
• Changes in insulin regimen dosage, injection timing, diet, or physical activity may increase risks of hyperglycemia or hypoglycemia. Patients switching to Awiqli should follow medical supervision, carefully monitor blood sugar frequently, and report glucose changes or symptoms to healthcare providers.
• Serious hypersensitivity reactions, including skin reactions or breathing difficulties, may occur with Awiqli use. Patients experiencing swelling, rash, itching, dizziness, or trouble breathing should seek immediate medical attention. Treatment should be stopped if reactions are confirmed by healthcare professionals promptly.
• Awiqli may lower potassium levels in the blood, leading to hypokalemia. Severe hypokalemia can affect heart rhythm and muscle function. Patients with kidney problems or those using potassium-lowering medicines should undergo regular monitoring and follow clinicians’ recommendations during treatment.
• Patients who are pregnant or planning pregnancy should consult healthcare providers before using Awiqli. Blood glucose control during pregnancy is important for maternal and fetal health. Insulin requirements may change throughout pregnancy, requiring careful monitoring, dose adjustments, and medical supervision.
• Never share an Awiqli FlexTouch pen or needle between patients, even if the needle appears changed. Sharing may spread serious infections or blood-borne diseases. Each pen should only be used by one person and stored according to the healthcare instructions provided.

What documents are required to import AWIQLI to India?

AWIQLI (insulin icodec-abae) Injection may be imported by patients or government hospitals in the patients’ names only.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is AWIQLI available in India?

AWIQLI (Insulin icodec-abae Injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Awiqli in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Awiqli price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

AWIQLI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of AWIQLI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Awiqli cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source AWIQLI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Awiqli®?

Insulin icodec-abae is the Generic Name for the trade name drug Awiqli®.

What is the Manufacturer’s Name of Awiqli®?

Awiqli® is manufactured by Novo Nordisk.

Is Awiqli® approved by the FDA?

Yes. Awiqli® is approved by the FDA. Date of first approval: March 26, 2026.

What strengths and dosage forms are available for Awiqli®?

Awiqli® is available as a clear and colourless solution for injection in a pre-filled pen (700 units per 1 mL) and comes in the following package sizes:

• Awiqli® FlexTouch®: 1 mL pre-filled pen (700 units), Pack size of 1 (sample pack only)
• Awiqli® FlexTouch®: 1.5 mL pre-filled pen (1050 units), Pack size of 1
• Awiqli® FlexTouch®: 3 mL pre-filled pen (2100 units), Pack size of 1

What are the most common side effects of Awiqli® Injection?

The most commonly reported side effects of Awiqli are hypoglycemia, hypersensitivity reactions (e.g., urticaria, swelling of the face and lips), rash, injection site reactions, lipodystrophy, pruritus, edema, and weight gain.

What is the availability of Awiqli near Medanta Hospital in Gurgaon?

Patients receiving treatment near Medanta Hospital can buy Awiqli through a patient-specific import pathway. With a valid oncologist’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.

What is the availability of Awiqli in Bangalore?

Awiqli in Bangalore is not yet commercially marketed, but patients can still access it through regulated import provisions. Once prescribed by a treating clinician, the medicine is sourced internationally and supplied to the treating hospital.

Is Awiqli available at HCG Cancer, Bangalore?

Awiqli may not be routinely stocked in India. However, it can be accessed through a Named Patient Program (NPP) with a valid prescription from an oncologist at the hospital. Indian Pharma Network (IPN) can help facilitate the import of Awiqli at HCG Cancer, Bangalore.

What is the availability of Awiqli in Mumbai?

The patient can buy Awiqli in Mumbai via special access programs that allow the import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.

I want to buy Awiqli in Mumbai. How can I access it?

If you are looking to buy Awiqli in Mumbai, the first step is consultation with your oncologist. Once prescribed, the medicine can be sourced from global suppliers through a compliant import process and delivered to your treating hospital.

What is the availability of Awiqli in Chennai?

Patient access to Awiqli in Chennai is possible through special access programs such as Named Patient Programs (NPP), which allow the import of internationally approved medicines. The treatment is arranged and delivered directly to the hospital where the patient is receiving care, ensuring compliance with regulatory requirements.

I want to buy Awiqli in Chennai. How can I access it?

If you are looking to buy Awiqli in Chennai, the first step is to consult your oncologist. Upon prescription, the medicine can be sourced from global suppliers through a compliant import process under NPP and delivered to your treating hospital, such as Apollo Hospitals Chennai or Cancer Institute (WIA).

What is the availability of Awiqli in Hyderabad?

Awiqli is accessible in Hyderabad through special access programs like Named Patient Programs (NPP), which enable the legal import of medicines not widely available in India. The medication is delivered directly to the hospital where the patient is undergoing treatment.

I want to buy Awiqli in Hyderabad. How can I access it?

To access Awiqli in Hyderabad, patients should first consult their oncologist. Once prescribed, the medicine can be arranged through authorized channels under NPP guidelines and delivered to the treating hospital, such as Basavatarakam Indo-American Cancer Hospital.

I want to buy Awiqli in Bangalore. How can I access it?

Patients seeking access to Awiqli in Bangalore should consult their oncologist for evaluation and prescription. Following this, the medicine can be procured through compliant import channels and delivered to the treating hospital, such as HCG Cancer Bangalore.

Can I buy Awiqli at major hospitals like Tata, HCG Cancer, Apollo, or Fortis?

Awiqli can be accessed at leading hospitals such as Tata Memorial Centre, HCG Cancer, Basavatarakam Indo-American Cancer Hospital, Cancer Institute (WIA), Apollo Hospitals, Fortis Healthcare, Max Healthcare, Rajiv Gandhi Cancer Institute & Research Centre, Manipal Hospitals, and Kokilaben Dhirubhai Ambani Hospital through the Named Patient Program (NPP) with a valid oncologist’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

How does Awiqli Import in India work?

Awiqli Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Awiqli supplier in India?

Indian Pharma Network is a trusted Awiqli supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Awiqli cost in India?

Awiqli is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Awiqli prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Awiqli cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Awiqli be available in SAARC countries?

Apart from Gulf countries, Awiqli can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Awiqli in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Awiqli online in India?

Yes, one can buy Awiqli in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Awiqli through legal channels.

Who is an authorized Awiqli importer in India?

Indian Pharma Network acts as the Awiqli importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

In which countries is Awiqli approved?

Awiqli (Insulin icodec-abae) has been approved in the United States, the European Union (EU), Canada, Japan, Switzerland, and Mainland China, along with several other countries (13 additional) for the treatment of adults with diabetes.

Can I buy Awiqli from Europe, the USA, or other countries?

As of now, Awiqli is approved and available in the United States, the European Union (EU), Canada, Japan, Switzerland, and Mainland China, but patients in India cannot directly purchase it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.

What are the storage conditions of Awiqli® Injection?

Store Awiqli® Injection refrigerated at 2°C–8°C, protect from light, do not freeze, and keep in original packaging.